AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 154 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $221,000 | +67.4% | 23,545 | +36.5% | 0.00% | +100.0% |
| Q2 2020 | $132,000 | +25.7% | 17,252 | +1.1% | 0.00% | 0.0% |
| Q1 2020 | $105,000 | -25.0% | 17,064 | +48.4% | 0.00% | 0.0% |
| Q4 2019 | $140,000 | +5.3% | 11,498 | -0.0% | 0.00% | 0.0% |
| Q3 2019 | $133,000 | +14.7% | 11,499 | -0.6% | 0.00% | 0.0% |
| Q2 2019 | $116,000 | -24.2% | 11,565 | -2.9% | 0.00% | -33.3% |
| Q1 2019 | $153,000 | -15.0% | 11,914 | +0.6% | 0.00% | -25.0% |
| Q4 2018 | $180,000 | -70.0% | 11,842 | +7.9% | 0.00% | -63.6% |
| Q1 2015 | $600,000 | -20.8% | 10,980 | -38.2% | 0.01% | 0.0% |
| Q4 2014 | $758,000 | – | 17,780 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,921,550 | $81,254,000 | 4.00% |
| Palo Alto Investors LP | 1,614,536 | $33,453,000 | 2.49% |
| Ghost Tree Capital, LLC | 100,000 | $2,072,000 | 1.46% |
| March Altus Capital Management LP | 146,418 | $3,034,000 | 1.11% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 296,458 | $6,143,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 999,339 | $20,706,000 | 0.83% |
| Visium Asset Management, LP | 2,070,870 | $42,908,000 | 0.67% |
| AlphaOne Investment Services, LLC | 97,448 | $2,019,000 | 0.54% |
| CONTINENTAL ADVISORS LLC | 57,438 | $1,190,000 | 0.28% |
| Tamarack Capital Management, LLC | 64,080 | $1,222,000 | 0.25% |